Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Appointment of Mr. Ankur Kharbanda as Whole-time Director of the company w.e.f. May 07, 2025.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.4 pts more than Nifty Smallcap 250 and 7.8 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Niva Bupa's board, at its May 7, 2025 meeting, approved the appointment of Mr. Vishwanath Mahendra (current CFO) and Mr. Ankur Kharbanda (current Chief Distribution Officer) as Whole-time Directors for five-year terms starting May 7, 2025, subject to shareholder and IRDAI approval. The board also accepted the resignation of Ms. Joanne Elizabeth Woods as Senior Vice President & Chief Risk Officer effective May 7, 2025, and appointed Mr. Vipul Sharma (ex-Bharti AXA Life Insurance CRO) as her replacement from May 8, 2025. Additionally, M/s Nangia & Co. LLP was appointed as Statutory Auditor for four years (2025-2029) and M/s Ranjeet Pandey & Associates as Secretarial Auditor for five years. The board also approved grant of 63,12,187 Employee Stock Options to eligible employees under the ESOP 2024 scheme.
Internal elevation of the existing CFO and Chief Distribution Officer to Whole-time Director roles signals continuity in leadership and recognition of long-tenured executives. Smooth CRO transition (with replacement already lined up) and new auditor appointments strengthen governance. ESOP grant of ~63 lakh shares may create mild dilution and is positive for employee retention.